NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
10-K - BIOREGENX, INC.
Filed:
2026-04-15
AccNo:
0001683168-26-002975
Size:
6 MB
发布时间04/15 17:51 UTC
首次发现04/15 17:54 UTC
热度107.9
重要度90
情绪+0.03
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 754 字符
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001683168-26-002975
Filing Date: 2026-04-15
Accepted: 2026-04-15 13:51:34
Documents: 79
Period of Report: 2025-12-31
BIOREGENX, INC. (Filer) CIK : 0001593184 (see all company filings) EIN. : 462836541 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 10-K | Act: 34 | File No.: 000-56345 | Film No.: 26863595 SIC : 7370 Services-Computer Programming, Data Processing, Etc. (CF Office: 06 Technology)
1 | FORM 10-K FOR DEC 2025 | bioregenx_i10k-123125.htm iXBRL | 10-K
2 | DESCRIPTION OF THE REGISTRANT'S SECURITIES | bioregenx_ex0401.htm | EX-4.1
3 | SUBSIDIARIES | bioregenx_ex2100.htm | EX-21
4 | 302 CERTIFICATION - CEO | bioregenx_ex3101.htm | EX-31.1